Startups
Seagen is dedicated to revolutionizing cancer care and improving patient outcomes with small-molecule technologies.
Overview
Location
United States, Washington, Bothell
Employees
11-50
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 10, 2009 | Oncothyreon Partner Starts New Lung Cancer Trial, Prompts Takeover Scuttle | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Seattle-based Oncothyreon (NASDAQ: ONTY), the developer of a vaccine treatment to stimulate the immune system against cancer cells, said today that its partner has started ano... |
| Former Dendreon CEO launches stealth next-gen immunotherapy startup in Seattle | Dendreon may be on its last legs, but former CEO Mitchell Gold is happily entrenched in other projects: He’s launching a next-generation immunotherapy startup called Alpine Immune Sciences, seeding about $1.3 million into the company throug... |
Reviews 0
FAQ about Seagen
What has the press written about Seagen?
Parsers VC has collected 3 articles mentioning Seagen, among them “Oncothyreon Partner Starts New Lung Cancer Trial, Prompts Takeover Scuttle” (Dec 10, 2009) and “Former Dendreon CEO launches stealth next-gen immunotherapy startup in Seattle”.
Is Seagen still active?
Yes, Seagen is active; its latest activity on Parsers VC dates from Feb 5, 2015.